Jayant Agro Organics clears Q3 FY26 results, postal ballot
Jayant Agro Organics Ltd
JAYAGROGN
Ask AI
Jayant Agro Organics board meeting update
Jayant Agro-Organics Limited informed the BSE that its Board of Directors meeting was scheduled for Friday, February 06, 2026. The company said the board would, among other items, take on record the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025. The disclosure was made under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The filing later reflected that the board meeting on February 06, 2026 covered multiple matters beyond routine financial reporting. Along with approval of the unaudited results, the board took up corporate governance proposals, including a director re-appointment and adoption of a new set of Articles of Association. The information cited in this update is drawn from the company’s filings submitted to the BSE.
What was disclosed in the January 30, 2026 intimation
The intimation dated January 30, 2026 stated that the board meeting would consider unaudited financial results for the quarter and nine months ended December 31, 2025. The company explicitly referenced that results would include both standalone and consolidated numbers.
The same context also linked the board meeting to compliance requirements under SEBI’s listing and disclosure framework. Such intimations are commonly used to inform the market about the timing of result approvals and other agenda items that may require disclosure.
February 6, 2026 board meeting: agenda expanded beyond results
Following the meeting held on February 06, 2026, Jayant Agro-Organics announced its quarterly financial results for the third quarter ended December 31, 2025. The filing also described several corporate matters addressed in the meeting apart from the financial result approval.
One of the headline items was the board’s action on the re-appointment of an Independent Director, along with other governance steps that were planned to be taken to shareholders for approval. The disclosures show that the board’s deliberations were not limited to financial reporting and included changes that may require member approvals.
Approval of unaudited results for Q3 FY26 and nine months
The company stated that the board was to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025. The board meeting record also captured that unaudited Q3 FY26 results were approved.
While the filing context here focuses on governance and process, it indicates that the company followed its standard results approval cycle through a board meeting and then communicated the outcome through exchange filings.
Independent Director re-appointment: term and identification details
The board recommended the re-appointment of Mr. Sanjay J. Mariwala as an Independent Director for a second term of five years. The term was stated as effective from June 30, 2026 to June 29, 2031, and was tied to member approval.
The company also disclosed his DIN as 01111537. By explicitly linking the re-appointment to member approval, the filing indicates that shareholder consent was a required next step before the re-appointment becomes effective.
Articles of Association and the postal ballot route
The board approved the adoption of a new set of Articles of Association. It also approved a postal ballot notice to seek member approvals for a set of proposals, including borrowing, creation of charges, investments, and other related governance changes.
In practical terms, the use of a postal ballot signals that the company intended to take these approvals to shareholders without waiting for a physical meeting cycle. The filing narrative positioned these actions as part of broader corporate governance initiatives.
Trading window closure: key compliance dates disclosed
The disclosure set includes trading window closure periods tied to board meetings for results. For the February 2026 results cycle, the note states that the trading window was closed from January 1 to February 10, 2026.
The historical examples included in the text show the company has followed similar closure practices in earlier periods as well, with start and end dates aligned around results consideration and disclosure.
How the February 2026 meeting fits into earlier board meeting intimations
The text also references earlier board meeting intimations around financial results:
- October 28, 2023: Meeting scheduled to take on record unaudited results for the quarter and half year ended September 30, 2023. Trading window closed from October 01, 2023 to October 31, 2023 (both days inclusive).
- July 26, 2025: Meeting scheduled to take on record unaudited results for the quarter ended June 30, 2025. Trading window closed from July 01, 2025 to July 29, 2025 (both days inclusive).
- November 08, 2025: Meeting scheduled to take on record unaudited results for the quarter and half year ended September 30, 2025. Trading window closed from October 01, 2025 to November 11, 2025 (both days inclusive).
- November 11, 2022: Meeting scheduled to take on record unaudited results for the quarter and half year ended September 30, 2022. Trading window closed from October 1, 2022 to November 15, 2022 (both days inclusive).
These references provide a timeline of periodic result-related board meetings and the related compliance steps.
Key facts from the February 6, 2026 board meeting
Timeline of referenced board meeting and trading window closures
Market and governance relevance for shareholders
The February 06, 2026 board meeting matters for shareholders on two clear tracks visible in the disclosures. First, it completes the formal process for approving unaudited results for the quarter and nine months ended December 31, 2025. Second, it bundles key governance actions that will move to shareholder approval through a postal ballot.
From a governance lens, the re-appointment of an Independent Director for a defined five-year term and the adoption of a new set of Articles of Association are typically considered material governance actions. The filing also indicates that additional member approvals were proposed for borrowing, charges, and investments, which suggests the company wanted explicit shareholder authorisation for those items.
What to watch next based on the filing
The filing points to member approvals as the next formal step for the re-appointment of Mr. Sanjay J. Mariwala and for the postal ballot items, including adoption of the new Articles of Association and other approvals referenced. Investors tracking compliance milestones would generally look for the postal ballot process and related outcomes to be communicated through exchange filings.
Separately, the company has already indicated that the board approved unaudited Q3 FY26 results. As with other result cycles referenced in the disclosure set, subsequent filings typically complete the market communication chain around board approvals, window closures, and shareholder approvals where applicable.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker